The funding is supporting proof-of-concept stage projects that will deliver genomics/genomics-derived technologies, tools and processes to provide solutions to industry-identified challenges or opportunities within the sector. ON-RP3 will help industry take applied research to the implementation and commercialization stages. These solutions will be implemented by 2024.